Comparison of Receptors and Enzymes Regulating Cholesterol Levels in Liver between SHR/NDmcr-cp Rats and Normotensive Wistar Kyoto Rats at Ten Weeks of Age
スポンサーリンク
概要
- 論文の詳細を見る
The spontaneously hypertensive rat (SHR)/NDmcr-cp (SHR-cp), which is a metabolic syndrome model rat, was reported to show hypercholesteremia, as compared with lean littermates. The serum total cholesterol level in SHR-cp at 18 weeks of age is higher than that of normotensive Wistar Kyoto rat (WKY), but that in SHR-cp at 10 weeks of age is the same. The objective of this study is to clarify whether there are differences in the system regulating serum cholesterol levels between SHR-cp and WKY at 10 weeks of age. Total serum cholesterol levels, and cholesterol levels of high density lipoprotein (HDL), low density lipoprotein (LDL), and very low density lipoprotein (VLDL) were similar in the two strains. However, the cholesterol levels in the liver of SHR-cp were lower than those of WKY. Next, mRNA levels of receptors (scavenger receptor class B type 1 [SRB1], LDL receptor [LDLR]) involved in uptake from serum to liver or enzymes of cholesterol catabolism (CYP7A1 and CYP8B1) and biosynthesis (mevalonate pyrophosphate decarboxylases [MPD]) in liver were compared between SHR-cp and WKY. High levels of MPD and LDLR and low levels of SRB1 were shown in SHR-cp, as compared with WKY. CYP7A1 and CYP8B1 levels were similar between SHR-cp and WKY. These results suggest that the serum cholesterol level in SHR-cp by the balance or regulation between the rise in cholesterol uptake and reduction in cholesterol biosynthesis in the liver is the same as that in WKY.
著者
-
MICHIHARA Akihiro
Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
-
AKASAKI Kenji
Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
-
Miura Ayako
京都府立医科大学 法医学
-
Akasaki Kenji
Faculty Of Pharmacy & Pharmaceutical Sciences Of Fukuyama University
-
Anraku Makoto
Fac. Of Pharmacy And Pharmaceutical Sciences Fukuyama Univ.
-
Anraku Makoto
Faculty Of Pharmaceutical Sciences Kumamoto University
-
Tomida Hisao
Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
-
Abe Aoi
Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
-
Kinoshita Haruko
Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
-
Kamizaki Yohei
Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
関連論文
- Probucol Decreases Mevalonate Pyrophosphate Decarboxylase in the Rat Liver(Biochemistry/Molecular Biology)
- Pharmacological Studies of Alcohol Susceptibility and Brain Monoamine Function in Stroke-Prone Spontaneously Hypertensive Rats (SHRSP) and Stroke-Resistant Spontaneously Hypertensive Rats (SHRSR)
- Peroxisome Proliferative Drugs Do not Induce an Increase of Rat Mevalonate Pyrophosphate Decarboxylase(Biochemistry/Molecular Biology)
- Comparison of Subcellular Distribution of Mevalonate Pyrophosphate Decarboxylase between Stroke-Prone Spontaneously Hypertensive Rat and Wistar Kyoto Rat
- Mevalonate Pyrophosphate Decarboxylase in Stroke-Prone Spontaneously Hypertensive Rat Is Reduced from the Age of Two Weeks
- Difference in Subcellular Distribution between 45- and 37-kDa Mevalonate Pyrophosphate Decarboxylase in Rat Liver
- Mevalonate Pyrophosphate Decarboxylase is Predominantly Located in the Cytosol of Rat Hepatocytes
- Distribution of Twenty-Four Hour Urinary Taurine Excretion and Association with Ischemic Heat Disease Mortality in 24 Populations of 16 Countries : Results from the WHO-CARDIAC Study
- Comparative Studies of Diet-Related Factors and Blood Pressure among Chinese and Japanese : Results from the China-Japan Cooperative Research of the WHO-CARDIAC Study
- Cardiovascular Risk Factors Emerging in Chinese Populations Undergoing Urbanization
- The Antioxidative and Antilipidemic Effects of Different Molecular Weight Chitosans in Metabolic Syndrome Model Rats
- Lower Mevalonate Pyrophosphate Decarboxylase Activity Is Caused by the Reduced Amount of Enzyme in Stroke-Prone Spontaneously Hypertensive Rat
- Purification and Characterization of Two Mevalonate Pyrophosphate Decarboxylases from Rat Liver: A Novel Molecular Species of 37 kDa
- Effect of Olmesartan on Oxidative Stress in Hemodialysis Patients
- Oxidation and Carboxy Methyl Lysine-Modification of Albumin : Possible Involvement in the Progression of Oxidative Stress in Hemodialysis Patients
- Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population
- Change in the Protein Level of Mevalonate Pyrophosphate Decarboxylase in Tissues of Mouse by Pravastatin(Biochemistry/Molecular Biology)
- Subcellular Distribution of Mouse Mevalonate Pyrophosphate Decarboxylase
- Purification and Characterization of Mouse Mevalonate Pyrophosphate Decarboxylase
- Tissue Distribution of a Major Mevalonate Pyrophosphate Decarboxylase in Rats
- Comparison of the Gene Expression Levels of Mevalonate Pyrophosphate Decarboxylase between Stroke-prone Spontaneously Hhypertensive and Wistar Kyoto Rats
- Tissue Distribution of Mevalonate Pyrophosphate Decarboxylase in Guinea Pig
- High Levels of Oxidative Stress Exist in the Brain than Serum or Kidneys in Stroke-Prone Spontaneously Hypertensive Rats at Ten Weeks of Age
- Purification and Characterization of a Major Kyotorphin-Hydrolyzing Peptidase of Rat Brain
- The Structural and Pharmacokinetic Properties of Oxidized Human Serum Albumin, Advanced Oxidation Protein Products (AOPP)
- Kinetic Studies of Covalent Binding between N-acetyl-L-cysteine and Human Serum Albumin Through a Mixed-disulfide Using an N-methylpyridinium Polymer-based Column
- Distribution of a Major Lysosomal Membrane Glycoprotein, LGP85/LIMP II, in Rat Tissues
- Identification and Characterization of a Major Lysosomal Membrane Glycoprotein, LGP85/ LIMP II in Mouse Liver
- Inhibition of Rabbit Heart Carbonyl Reductase by Fatty Acids
- Comparison of Receptors and Enzymes Regulating Cholesterol Levels in Liver between SHR/NDmcr-cp Rats and Normotensive Wistar Kyoto Rats at Ten Weeks of Age
- Effect of Telmisartan on Ambulatory Blood Pressure Monitoring, Plasma Brain Natriuretic Peptide, and Oxidative Status of Serum Albumin in Hemodialysis Patients
- Reduction of Mevalonate Pyrophosphate Decarboxylase in Mouse Melanoma Cells Treated with δ-Tocotrienol Is Not Associated with Reduction of Cholesterol Content or Release of Lysosomes and Melanosomes
- Delta-Tocotrienol Causes Decrease of Melanin Content in Mouse Melanoma Cells
- Difference in Subcellular Distribution of Mevalonate Pyrophosphate Decarboxylase Occurs by Cell Type
- Mevalonate Pyrophosphate Decarboxylase is Predominantly Located in the Cytosol of both B16 and B16F10 Cells in Mouse Melanoma Treated with Lovastatin
- The Effect of Primaquine on Lysosomal Protein in Cultured Rat Hepatocytes
- Decrease of Cholesterol in Mouse Melanoma Causes Secretion of Lysosomal Enzymes
- Disruptive Effect of Chloroquine on Lysosomes in Cultured Rat Hepatocytes(Biochemistry/Molecular Biology)
- Biosynthetic Transport of a Major Lysosome-Associated Membrane Glycoprotein 2, Lamp-2: A Significant Fraction of Newly Synthesized Lamp-2 Is Delivered to Lysosomes by Way of Early Endosomes
- Effect of Delta-Tocotrienol on Melanin Content and Enzymes for Melanin Synthesis in Mouse Melanoma Cells
- Evaluation for Antioxidant and Renoprotective Activity of Olmesartan Using Nephrectomy Rats
- COOH-terminal isoleucine of lysosome-associated membrane protein-1 is optimal for its efficient targeting to dense secondary lysosomes
- Identification and Characterization of a Major Lysosomal Membrane Glycoprotein, LGP85/LIMP II in Mouse Liver.